The Effect of Pilates and Myofascial Release on Flexibility

July 4, 2023 updated by: Kübra Torpi, Saglik Bilimleri Universitesi

The Effect of Instrumental Pilates and Myofascial Release on Flexibility, Muscle Strength, Dynamic Balance, Neural Tension and Pain Threshold

The aim of this study is to compare the short and long term effects of pilates and myofascial relaxation technique on flexibility, muscle strength, dynamic balance, neural tension and pain threshold. To evaluate the effects of myofascial release technique on neural tension. To evaluate the effects of pilates on neural tension. To evaluate the effects of the protocol applied in combination with pilates and myofascial release technique in healthy women.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Completed

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

Pilates is a synthesis of balance, breathing and movement systems that predict the unity of mind and body developed by Joseph Pilates. Breathing correctly and adequately allows more oxygen to go to all the tissues in our body. Pilates; It includes 6 key principles: breath, concentration, control, precision / accuracy, centering, rhythm / fluency. It activates every muscle in the body, gives balance and flexibility, and shapes the posture by improving the body. By correcting the posture, it protects the musculoskeletal system problems caused by the posture disorder and helps the body to be more flexible and increase the strength and endurance of the muscles. It provides control over all joint movements, especially the spine. It improves balance and coordination. Fascia is a single, inseparable connective tissue that wraps, supports, protects, connects all tissues. It is a dynamic structure with many sensory receptors, constantly changing and adaptable, it is the largest system in the human body. Myofascial release technique can be defined as low-intensity, long-term mechanical force applied to the myofascial complex in order to dissolve fascial adhesions, reduce pain, ensure optimal length of the muscle, and increase functionality. It has been shown that myofascial release applied to the hamstrings in healthy individuals provides an increase in the normal range of motion of the hip. The effects of Pilates and myofascial release technique on flexibility, muscle strength, dynamic balance, neural tension and pain threshold will be evaluated.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Actual)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
26

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact

The name and contact information for the person who can answer enrollment questions for a clinical study. Each location where the study is being conducted may also have a specific contact, who may be better able to answer those questions.

Study Contact Backup

Study Locations

  • Turkey
    • Uskudar
      • Istanbul, Uskudar, Turkey
        • Saglik Bilimleri University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

18 years to 50 years (Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Be between the ages of 18-50
  • Be woman Having a score of 600 or more when the International Physical Activity Questionnaire (Short) was administered
  • Not be in menopause
  • Not having had lower extremity surgery
  • No traumatic injury in the last 1 year

Exclusion Criteria:

  • Women entering menopause
  • International Physical Activity Questionnaire (Short) score less than 600
  • Those who have had lower extremity surgery
  • Those with traumatic injury in the last 1 year

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Experimental: Pilates exercise and myofascial release group
In this study, pilates exercise and myofascial release technique will be applied for 8 weeks, 2 days a week. Participants will be evaluated at the beginning of the study, at the end of the first session and after 8 weeks.
Other: Pilates exercise and myofascial release
Pilates exercise and myofascial relaxation technique will be applied to the experimental group and pilates exercise will be applied to the control group.
Other Names:
  • Pilates exercise
Active Comparator: Pilates Exercise
In this study, pilates exercise will be applied for 8 weeks, 2 days a week. Participants will be evaluated at the beginning of the study, at the end of the first session and after 8 weeks.
Other: Pilates exercise and myofascial release
Pilates exercise and myofascial relaxation technique will be applied to the experimental group and pilates exercise will be applied to the control group.
Other Names:
  • Pilates exercise

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Assessment of popliteal angle test
Time Frame: 8 weeks
It will be used to assess hamstring muscle shortness. The person lies on his back. While the non-tested leg and back are fixed on the ground, the tested hip is 90 degrees flexed and tries to extend the knee. The value measured with the goniometer is recorded.
8 weeks
Assessment of Weight beating lunge test
Time Frame: 8 weeks
It will be used to assess gastrocnemius flexibility. In front of the wall, the person tries to contact the wall with his knee without the sole of his feet rising from the ground. The non-tested leg can stay in the desired position and put the knee on the ground. The foot is expected to be at the maximum distance from the wall so that the knee on the tested side does not break contact with the wall. The distance between the big toe and the wall is recorded.
8 weeks

Secondary Outcome Measures

Secondary Outcome Measures

In a clinical study's protocol, a planned outcome measure that is not as important as the primary outcome measure for evaluating the effect of an intervention but is still of interest. Most clinical studies have more than one secondary outcome measure.
Outcome Measure
Measure Description
Time Frame
Assessment of Back leg chest dynamometer test
Time Frame: 8 weeks
The feet should be on the dynamometer with the sole in full contact. The chain of the dynamometer is adjusted so that the hips and knees are slightly flexed. The person grabs the handles with his hands and pulls them towards himself without disturbing the foot contact. 3 repetitions are performed and the maximum value is recorded.
8 weeks
Assessment of dynamometer test
Time Frame: 8 weeks
The muscle strength of the hamstring and gastro muscles will be evaluated with a hand dynamometer. The person is asked to reveal movement. At this time, resistance is given with a dynamometer. Maximum resistance is created for a few seconds. The test is repeated 3 times and the maximum value on the dynamometer is recorded.
8 weeks
Assessment of Slump test
Time Frame: 8 weeks
This test will be used to assess femoral nerve tension. The person sits on the chair with the hips and knees at 90º. Flexes the trunk first and then the neck. He then extends the knee and dorsiflexes the ankle. The maximum angle at which the patient can dorsiflex the ankle is measured.
8 weeks
Assessment of Laseque test
Time Frame: 8 weeks
It will be used to assess sciatic nerve tension. While the person is lying on his back, he is asked to raise his leg straight with the knee extended. The maximum lifted angle is noted. The test is repeated 3 times and the maximum value is recorded.
8 weeks
Assessment of algometer
Time Frame: 8 weeks
Pressure algometers developed by Fischer can measure up to 10 kg in kg/cm². There is a metal rod with a 1 cm² rubber on the end. This rubber tip ensures that the applied force is transmitted to the deep tissues. The rate and precision of the indicator allows measurement of both deep and superficial trigger points. As with other methods that evaluate trigger points, the muscles must be relaxed in order to be able to measure accurately. The tip of the pressure algometer is touched at a 90° angle to the point of the most intense sensitivity and the pressure is increased until the patient verbally expresses his discomfort. The application is repeated 3 times and the average value is recorded. For the hamstring, measurements will be taken from the recommended trigger points on the semitendinosus, semimembranosus and biceps femoris. For the gastrocnemius muscle, the measurement will be taken from the medial third of the muscle and 2 cm from the most bulging part of the muscle.
8 weeks
Assessment of star excursion balance test
Time Frame: 8 weeks
It will be used to assess dynamic balance. 4 strips cut in 2 meters length are adhered to form 45 degree angles between them. The person stands in the middle of the star shape. When stretching with the right foot, it moves clockwise, when stretching with the left foot, it moves counterclockwise. During the test, the hands should be on the waist and their position should not change. The person reaches as far as he can reach with his foot and touches the strip lightly with the tip of his finger and returns to the starting point. Then it is continued with the other line and 8 stretches are performed in this way. The tester then draws a line with a pencil at the last point he reaches to measure. The test is repeated 3 times and the other foot is switched. The distances reached are recorded.
8 weeks
Assessment of single leg stance test
Time Frame: 8 weeks
It will be used to evaluate static balance. The non-dominant foot is lifted on the hips and the hands are placed on the leg at the other knee level. The time he held his position is recorded. The test is repeated 3 times, the most successful result is saved. The test is repeated in the same way with the eyes closed.
8 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Saglik Bilimleri Universitesi

Investigators

Investigators

A researcher involved in a clinical study. Related terms include site principal investigator, site sub-investigator, study chair, study director, and study principal investigator.
  • Principal Investigator: Hatice Kübra Torpi Ceylan, MSc PT, Saglik Bilimleri Universitesi

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
January 1, 2023

Primary Completion (Actual)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
April 10, 2023

Study Completion (Actual)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
June 12, 2023

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
November 26, 2022

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
November 26, 2022

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
December 9, 2022

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
July 6, 2023

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
July 4, 2023

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
July 1, 2023

More Information

Terms related to this study

Keywords

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • Pilates Exercise

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings